Streetbeat News

ABL

Abacus Life, Inc.

Industry

Insurance - Life

Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.

Open

8.44

Mkt cap

623M

Volume

41K

High

8.51

P/E Ratio

-37.91

52-wk high

13.25

Low

8.12

Div yield

N/A

52-wk low

5.85

Abacus Life, Inc. (NASDAQ:ABL) has announced a new national distribution agreement with AIMCOR, a major insurance marketing organization. Abacus will become a preferred partner for life settlement solutions within AIMCOR's extensive network.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 12:41 pm

B. Riley Securities has initiated coverage on Abacus Life (NASDAQ:ABL) with a Buy rating and a price target of $16, as announced by analyst Matt Howlett.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 1:06 pm

Shares of Applied DNA Sciences (APDN) fell sharply by 67.5% after announcing a $12 million public offering. Other notable stock movements include Sharps Technology (STSS) climbing 207%, Insmed Incorporated (INSM) jumping 110% on positive Phase 3 study results, and Pineapple Energy (PEGY) gaining 91.5% after a subsidiary signed a significant project. Several other stocks experienced significant gains and losses during Tuesday's mid-day session.

Portfolio Pulse from Avi Kapoor

May 28, 2024 | 5:24 pm

Several US-listed stocks saw significant gains on Tuesday. Nvidia rose 4.4% due to reports of Elon Musk's xAI plans and strong financial results. Insmed climbed 110% after positive Phase 3 study results. Calliditas Therapeutics rose 74.6% following a board recommendation to accept a tender offer. Other notable gainers include Agios Pharmaceuticals, Arcturus Therapeutics, and GameStop.

Portfolio Pulse from Avi Kapoor

May 28, 2024 | 2:31 pm

Abacus Life (NASDAQ:ABL) reported a decrease in Q1 EPS to $0.11 from $0.15 YoY, while sales surged to $21.49M from $10.27M YoY.

Portfolio Pulse from totan@benzinga.com

May 13, 2024 | 11:14 am

Abacus Life reported an adjusted EPS of $0.11 for Q4, indicating its financial performance during the quarter.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 8:40 pm

Abacus Life (NASDAQ:ABL) reported a 25.53% increase in Q4 sales, reaching $23.60 million up from $18.80 million YoY.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 8:19 pm

Numerous companies are scheduled to report their earnings on March 21, 2024, covering a wide range of industries from technology to healthcare. The reports include a mix of expected quarterly earnings and losses, with notable companies such as Welltower, Academy Sports, Exscientia, Direxion Daily CSI China Internet Index Bull 2X Shares, and Winnebago Industries among those reporting before the bell. After the bell, companies like Lululemon Athletica, Nike, FedEx, and Intellicheck will report, providing insights into their financial health and performance.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 10:15 am

In Wednesday's intraday session, the insurance industry saw notable movements. Marpai, Abacus Life, Cheche Group, Intl General Insurance, Kingstone Companies, and Hippo Holdings were gainers, with increases ranging from 2.94% to 8.84%. Conversely, James River Gr Hldgs, Universal Insurance Hldgs, Reliance Global Group, United Fire Gr, Donegal Gr, and Crawford were losers, with decreases ranging from 1.35% to 3.73%. Intl General Insurance's Q4 earnings were released yesterday.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 5:40 pm

Abacus Life has announced a public offering of $25M in additional 9.875% notes due 2028, fully fungible with the existing $35.65M notes issued on November 10, 2023. This will increase the total notes to $60.65M. An option for underwriters to purchase up to an additional $3.75M in notes for overallotments is included. The offering is set to close on February 15, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:36 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.